Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05
Tweet Send to a FriendGet Alerts NABI Hot Sheet
Price: $1.80 --0%
EPS Growth %: -71.4%
Financial Fact:
Revenue: 12.5M
Today's EPS Names:
NED, OESX, WSTL, More
EPS Growth %: -71.4%
Financial Fact:
Revenue: 12.5M
Today's EPS Names:
NED, OESX, WSTL, More
Trade NABI Now!
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Synopsys, Inc. (SNPS) Tops Q1 EPS by 3c, Offers Guidance
- Pacific Sunwear Of California (PSUN) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
